| Financial Year |
March 31 2023 |
| Monetary Funds |
2,888,392,281.13 |
| Held-for-trading Financial Assets |
311,172,275.61 |
| Notes Receivable |
1,305,584,225.56 |
| Accounts Receivable |
918,505,081.33 |
| Advances to Suppliers |
391,876,036.34 |
| Other Receivables |
91,356,950.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
959,833,869.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
103,124,168.63 |
| Total Current Assets |
7,508,152,254.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
6,050,888,576.59 |
| Under-construction Projects |
2,077,954,075.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
993,784,059.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,408,355.96 |
| Deferred Income Tax Assets |
218,923,959.17 |
| Other Non-Current Assets |
197,742,606.27 |
| Sub-Total of Non-Current Assets |
9,558,392,938.58 |
| Total Assets |
17,066,545,192.64 |
| Short-Term Loans |
3,962,774,202.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,566,386.52 |
| Accounts Payable |
1,259,865,452.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,329,259.82 |
| Taxes Payable |
34,231,636.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,211,151.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,790,828.34 |
| Other Current Liabilities |
817,434,720.26 |
| Sub-Total of Current Liabilities |
6,572,523,927.04 |
| Long-term Loans |
749,500,000.00 |
| Bonds Payable |
930,364,796.35 |
| Long-Term Accounts Payable |
36,564,494.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
58,666,996.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,927,464,252.88 |
| Total Liabilities |
8,499,988,179.92 |
| Paid-In Capital(Or Share Stock) |
855,087,175.00 |
| Capital Surplus |
3,133,362,229.04 |
| Surplus Reserve |
549,657,381.09 |
| LESS:Treasury Stock |
75,107,395.89 |
| Undistributed Profits |
3,838,656,394.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,566,557,012.72 |
| Owner's Equity（Stockholder's Equity） |
8,566,557,012.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,066,545,192.64 |
